Observational Study of Dydrogesterone in Cycle Regularization
|ClinicalTrials.gov Identifier: NCT02029144|
Recruitment Status : Completed
First Posted : January 7, 2014
Last Update Posted : February 10, 2015
Dydrogesterone has been widely used worldwide for various gynecological and obstetric indications:
- Dydrogesterone is effective in cycle regulation treatment.
- Dydrogesterone is recognized as none interference to hypothalamus pituitary ovary (HPO) axis in the recommended dosage.
- Dydrogesterone might have non-negative effect on glucose and lipid metabolic.
|Condition or disease|
|Observational Study Dydrogesterone Irregular Menstrual Cycle Abnormal Uterine Bleeding|
|Study Type :||Observational|
|Actual Enrollment :||114 participants|
|Official Title:||Dydrogesterone in Cycle Regularization in Abnormal Uterine Bleeding - Ovulation Dysfunction (AUB-O) Patients: A Prospective, Observational Study|
|Study Start Date :||December 2013|
|Actual Primary Completion Date :||February 2015|
|Actual Study Completion Date :||February 2015|
- percentage of patients reporting a regular cycle (defined as cycle duration≥21 and ≤ 35 days) at the end of cycle 3 [ Time Frame: 12 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02029144
|Obstetrics and Gynecology Hospital of Fudan University|
|Shanghai, Shanghai, China, 200011|